Literature DB >> 15188772

Severe reversible left ventricular systolic and diastolic dysfunction due to accidental iatrogenic epinephrine overdose.

Navin Budhwani1, Kenneth L Bonaparte, Aloysius B Cuyjet, Muhamed Saric.   

Abstract

Catecholamine-induced cardiomyopathy due to chronic excess of endogenous catecholamines has been recognized for decades as a clinical phenomenon. In contrast, reports of myocardial dysfunction due to acute iatrogenic overdose are rare. A 35-year-old woman whose cervix uteri was inadvertently injected with 8 mg of epinephrine developed myocardial stunning that was characterized by severe hemodynamic compromise, profound, albeit transient, left ventricular systolic and diastolic dysfunction, and only modestly elevated biochemical markers of myocardial necrosis. Our case illustrates the serious consequences of medical errors that can be avoided through improved medication labeling and staff supervision.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15188772

Source DB:  PubMed          Journal:  Rev Cardiovasc Med        ISSN: 1530-6550            Impact factor:   2.930


  4 in total

1.  Iatrogenic epinephrine-induced reverse Takotsubo cardiomyopathy: direct evidence supporting the role of catecholamines in the pathophysiology of the "broken heart syndrome".

Authors:  Ivan V Litvinov; Mark A Kotowycz; Sven Wassmann
Journal:  Clin Res Cardiol       Date:  2009-06-10       Impact factor: 5.460

2.  Hypertension, tachycardia, and reversible cardiomyopathy temporally associated with milnacipran use.

Authors:  Mervyn B Forman; Paul G Sutej; Edwin K Jackson
Journal:  Tex Heart Inst J       Date:  2011

3.  Intravenous epinephrine overdose in prehospital management of suspected anaphylaxis.

Authors:  Jack Callum; Myles Rivlin; Patrick Carroll
Journal:  BMJ Case Rep       Date:  2020-01-08

4.  Cardiac arrhythmia from epinephrine overdose in epidural test dose.

Authors:  Shelly B Borden; Molly K Groose; Mark J Robitaille; Kristopher M Schroeder
Journal:  Saudi J Anaesth       Date:  2019 Jul-Sep
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.